Genex Pharma

Strength	250 mg
Brand	Abisam
Tablets per Pack	120 Tablets
Usage/Application	Hospital
Packaging Size	120 Tablets
Usage	Prostate Cancer
Form	Tablet
Prescription/Non prescription	Prescription
Country of Origin	Made in India
Pack Type	Box
Packaging Type	Bottle

Product Name: Abiraterone Acetate Tablets 250 MG
Brand Name:  Abisam
Srength: 250 MG
Packing: 30 Tablets per box

Abiraterone Acetate Tablets by Samarth Pharma represent a breakthrough in the treatment of metastatic castration-resistant prostate cancer (mCRPC), offering patients a potent therapeutic option that targets androgen receptor signaling pathways. These tablets contain abiraterone acetate, an orally active inhibitor of androgen biosynthesis that effectively suppresses the production of testosterone and other androgens, thereby slowing tumor progression and extending survival.
These tablets represent a significant advancement in the management of mCRPC, offering patients an effective treatment option that can improve outcomes and quality of life. With their proven efficacy and reliable performance, Samarth Pharma's Abiraterone Acetate Tablets are a trusted choice for healthcare providers and patients in the fight against metastatic prostate cancer.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 Tablets per box

Strength	50 mg
Brand	CALUDEC
Packaging Size	3 x 10 Tablets
Composition	Bicalutamide
Dosage Form	Tablet
Form	Tablet
Prescription	Prescription
Manufacturer	Samarth Life Sciences Pvt Ltd.

Product Name: Bicalutamide Tablets
Brand Name: Caludec
Strength: 50 mg
Packing: 30 Tablets Per Box
Manufacturer: Genex Pharma
Indication: Prostate cancer treatment in combination with luteinizing hormone releasing hormone analogs or following surgical castration.


Description

Caludec contains Bicalutamide, a potent, non-steroidal anti-androgen that binds to androgen receptors and inhibits the stimulatory effects of androgens (such as testosterone) on prostate cancer cells. Unlike steroidal anti-androgens, Bicalutamide has no hormonal agonist activity.

Mechanism of Action

Bicalutamide competes with natural androgens for binding to androgen receptors in prostate tissue. This blockade prevents androgen-stimulated transcription, leading to suppression of prostate cancer cell growth. It is typically used in combined androgen blockade (CAB) with LHRH analogs or after surgical castration to maximize androgen suppression.

Indications

Caludec is indicated for:

• Treatment of advanced prostate cancer in combination with an LHRH analogue or surgical castration.

• Use as part of combination therapy in metastatic hormone-sensitive prostate cancer (mHSPC).

Strength	50 mg
Brand	CALUDEC
Packaging Size	10X10 Tablets
Packaging Type	Strip
Composition	Bicalutamide
Dosage Form	Tablet
Prescription	Prescription

Product Name: Bicalutamide Tablet
Brand Name: Samtide
Strength: 50 MG
Packing: 100 Tablets Per Box

SAMTIDE (Bicalutamide Tablets 50 mg) is a potent non-steroidal anti-androgen that works by blocking the action of male hormones (androgens) in the body. It is widely used in the treatment of advanced prostate cancer, typically in combination with a luteinizing hormone-releasing hormone (LHRH) analog or surgical castration. SAMTIDE is developed under strict quality standards to ensure consistent therapeutic efficacy and patient safety.

IndicationsSAMTIDE 50 mg is indicated for:
Advanced prostate cancer (in combination with LHRH analogs or surgical castration)

Locally advanced prostate cancer at high risk of progression (as part of combined androgen blockade)

Key Benefits

 

• Effective androgen receptor blocker for prostate cancer management

• Well-tolerated oral therapy with once-daily dosing

• Manufactured under WHO-GMP standards for high quality and consistency

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 100 TABLETS PER BOX

Strength	250 mg
Packaging Size	150 Tablets
Pack Size	150 Tablets
Brand	ETIBO
Usage	Breast Cancer
Pack Type	Box
Brand Name	ETIBO
Packaging Type	Box
COMPOSITION	Lapatanib 250 MG
FORM	TABLET

Product Name: Lapatanib Tablets IP 250 MG
Brand Name: Etibo
Strength: 250 MG
Packing: 150 Tablets Per Box

1. Description:

   • Lapatinib is a tyrosine kinase inhibitor used in the treatment of certain types of cancer.
   • It is available in tablet form for oral administration.

2. Mechanism of Action:

   • Lapatinib inhibits the activity of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), which are proteins involved in cancer cell growth and proliferation.

3. Indications:

   • Treatment of HER2-positive breast cancer that has progressed despite other therapies.
   • Often used in combination with other anticancer drugs.

4. Administration:

   • Administered orally, usually once daily, with or without food.
   • Dosage and duration of treatment are determined based on the patient's weight, health status, and response to therapy.

5. Adverse Reactions:

   • Common side effects include diarrhea, nausea, vomiting, fatigue, and rash.
   • Cardiotoxicity, hepatotoxicity, and interstitial lung disease are potential serious adverse effects that may occur.

6. Contraindications:

   • Hypersensitivity to lapatinib or any of its components.
   • Severe liver impairment.
   • Concurrent use with certain medications that may prolong the QT interval or inhibit CYP3A4 metabolism.

7. Precautions:

   • Monitor cardiac function, liver function, and electrolyte levels regularly during treatment.
   • Use with caution in patients with a history of cardiac disease, liver impairment, or pulmonary disease.

8. Drug Interactions:

   • Lapatinib may interact with drugs that are metabolized by or affect CYP3A4 enzymes, potentially altering their efficacy or toxicity.
   • Avoid concomitant use with strong CYP3A4 inhibitors or inducers.

9. Storage:

   • Store lapatinib tablets at room temperature (15-30°C) in a dry place away from direct sunlight.
   • Keep the tablets in their original packaging to protect them from moisture.

10. Availability:

    • Lapatinib tablets are available in 250 mg strength, typically supplied in blister packs or bottles.

11. Monitoring and Follow-Up:

    • Monitor for signs of treatment response, disease progression, and adverse reactions throughout the course of therapy.
    • Adjust dosage or treatment schedule as necessary based on patient response and tolerability.

12. Emergency Management:

    • Be prepared to manage potential severe adverse effects such as cardiotoxicity, hepatotoxicity, or interstitial lung disease promptly and effectively.
    • Ensure healthcare providers prescribing and administering lapatinib are trained in oncology and chemotherapy management.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX

Strength	500 mg
Brand	Abisam
Tablets per Pack	60 Tablets
Packaging Size	60 Tablets
Usage	Cancer Care
Form	Tablet
Manufactured By	Samarth Life Science Pvt. Ltd
Country of Origin	Made in India
Pack Type	Box
Packaging Type	Bottle

Product Name: Abiraterone Acetate Tablets
Brand Name: Abisam
Strength: 500 MG
Packing: 60 Tablets Per Box

_{Product Description}

Abisam (Abiraterone Acetate Tablets 500 mg) by Genex Pharma is an oral androgen biosynthesis inhibitor designed for the treatment of advanced prostate cancer. Abiraterone selectively and irreversibly inhibits cytochrome P450 17A1 (CYP17A1), a key enzyme in androgen production, thereby suppressing androgen synthesis from the testes, adrenal glands, and prostate tumor tissues.

_Indications

Abisam is indicated in combination with prednisone/prednisolone for:
Metastatic Castration-Resistant Prostate Cancer (mCRPC) in adult men
Metastatic High-Risk Castration-Sensitive Prostate Cancer (mCSPC) in adult men

_Storage

• Store below 25°C in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 Weeks
• Packaging Details: 60 Tablets Per Box

Strength	500 mg
Brand	DUREA
Capsules per Pack	100 Capsules
Composition	Hydroxyurea
Usage	Sickle Cell Disease
Packaging Size	100 CAPSULES PER BOX
Manufactured By	Samarth life Sciences Pvt Ltd
Usage/Application	Clinical
Usage / Application	Hospital
Country of Origin	Made in India
Packaging Type	Box
Pack Type	Strip

Product Name: Hydroxyurea Capsules
Brand Name: Durea
Strength: 500 MG
Packing: 100 Capsules Per Box


Product Description

Durea (Hydroxyurea Capsules 500 mg) by Genex Pharma is an oral antineoplastic agent widely used in the management of certain cancers and hematological disorders. Hydroxyurea works by inhibiting ribonucleotide reductase, leading to suppression of DNA synthesis in rapidly dividing cells.

Indications

Durea is indicated for the treatment of:

 

• Chronic Myeloid Leukemia (CML)

• Locally advanced squamous cell carcinoma of the head and neck (excluding lip)

• Resistant ovarian carcinoma

• Sickle Cell Anemia (to reduce the frequency of painful crises and the need for blood transfusions)

Storage

• Store below 25°C, in a dry place

• Protect from light and moisture

• Keep out of reach of children

 

Strength	500 MG
Tablets per Pack	60 Tablets
Brand	SAMTICA / ABISAM
Usage	Cancer Care
Pack Type	Box
Product Name	ABIRATERONE ACETATE TABLETS
Manufactured By	Samarth Lifesciences
Country of Origin	Made in India
Packaging Type	30 TABLETS PER BOX , 120 TABLETS PER BOX

Product Name: Abiraterone Acetate Tablets 500mg 
Brand Name: Samtica
Strength: 500 MG
Packing: 60 Tablets Per Box
Manufacturer (India): Genex Pharma (also marketed by Samarth Life Sciences Pvt. Ltd.)
^{Mechanism of Action}

Abiraterone acetate is a prodrug that converts to abiraterone, which selectively inhibits CYP17 (17-hydroxylase/17,20-lyase)—an enzyme critical for androgen (testosterone and related hormones) biosynthesis. By blocking this enzyme, Samtica significantly reduces androgen production, starving prostate cancer cells of the hormones they need to grow.

^{Dosage & Administration}

 

• Administration Advice: Must be taken on an empty stomach—at least 1 hour before or 2 hours after a meal. Food increases absorption and can cause unpredictable blood levels and heightened side effects

Strength	500mg
Brand	CAPOSTAT
Pack Size	1*10 Tablets
Tablets per Pack	30 Tablets
Form	Tablet
Prescription Type	Prescription
Brand Name	CAPOSTAT
Shelf Life	18 Months
Packaging Size	3 x 10 Tablets
Generic Name	Capecitabine Tablets 500mg
Manufacturer	Samarth Life Sciences Pvt Ltd.
Country of Origin	Made in India
Pack Type	Box
Pack Type	Strips

Product Name: Capecitabine Tablets IP
Brand Name: Capostat
Strength: 500 MG
Packing: 30 Tablets Per Box

Capecitabine tablets are a chemotherapy medication used to treat various types of cancer, including breast, colorectal, and gastric cancers. Here's a brief description with pointers:

1. Purpose: Used to treat cancer by inhibiting the growth and spread of cancer cells.

2. Administration: Administered orally in tablet form, typically taken with food.

3. Mechanism of Action: Capecitabine is converted into its active form, which interferes with DNA synthesis in cancer cells, leading to cell death.

4. Indications: Used in the treatment of breast cancer, colorectal cancer, and gastric cancer, either alone or in combination with other chemotherapy agents.

5. Dosage: Dosage varies depending on the type and stage of cancer, as well as the patient's body surface area and overall health.

6. Side Effects: Common side effects may include nausea, vomiting, diarrhea, fatigue, hand-foot syndrome (palmar-plantar erythrodysesthesia), and decreased blood cell counts.

7. Contraindications: Capecitabine is contraindicated in patients with severe renal impairment, known hypersensitivity to the drug, or a deficiency in the enzyme dihydropyrimidine dehydrogenase (DPD).

8. Precautions: Caution should be taken in patients with hepatic impairment, coagulopathy, or a history of cardiotoxicity.

9. Storage: Store capecitabine tablets according to manufacturer instructions, typically at controlled room temperature and away from moisture and heat.

10. Patient Monitoring: Regular monitoring of blood counts, liver function tests, and renal function is necessary during treatment to assess for adverse effects and adjust dosage as needed.

11. Education: Patients should be educated on the importance of adherence to the prescribed dosage regimen, potential side effects, and measures to manage side effects effectively.

12. Follow-Up: Patients receiving capecitabine should undergo regular follow-up appointments with their healthcare provider to monitor treatment response and address any concerns or complications.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 WEEKS
• Packaging Details: 30 TABLETS PER BOX

Strength	50 mg
Brand	DASATIB-50
Tablets per Pack	60 Tablets
Pack Size	1*60 Tablet
Pack Type	Box
Usage	Cancer Care
Pack Type	Bottle
Form	Tablet
Brand Name	Dasatib
Manufacturer	SAMARTH LIFE SCIENCE PVT. LTD

Product Name: Dasatinib Tablets 50 MG
Strength:50 MG
Packing: 60 Tablets per Box
Brand Name: Dasatib 

• Name: Dasatinib Tablets 50 mg
• Purpose: Treats chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Active Ingredient: Dasatinib.
• Dosage Strength: 50 mg tablet.
• Dosage Form: Oral tablet.
• Mechanism of Action: Blocks proteins promoting cancer cell growth.
• Indications: Used for specific types of leukemia.
• Contraindications: Hypersensitivity.
• Adverse Reactions: Side effects include nausea, diarrhea, headache; serious reactions may include fluid retention, bleeding.
• Storage: Store at room temperature.
• Prescription: Typically by oncologists.
• Counseling: Advise on dosing, potential side effects.
• Pregnancy/Lactation: Use with caution; discuss risks.
• Interactions: Check for interactions with other medications, especially those metabolized by CYP3A4.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 60 TABLETS PER BOX

Strength	100 mg
Brand	DASATIB-100
Tablets per Pack	60 Tablets
Pack Size	1*30 Tablet
Pack Type	Box
Usage	CML
Pack Type	Bottle
Form	Tablet
Brand Name	DASATIB-100
Manufacturer	samarth life science pvt. ltd
Country of Origin	Made in India

Product Name: Dasatinib Tablet 100 MG
Brand Name: Dasatib
Strength: 100 MG
Packing: 30 Tablets per box

• Name: Dasatinib Tablet 100 mg
• Purpose: Treats chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Active Ingredient: Dasatinib.
• Dosage Strength: 100 mg tablet.
• Dosage Form: Oral tablet.
• Mechanism of Action: Inhibits proteins promoting cancer cell growth.
• Indications: Specifically for certain types of leukemia.
• Contraindications: Hypersensitivity.
• Adverse Reactions: Side effects include nausea, diarrhea, headache; severe reactions may include fluid retention, bleeding.
• Storage: Keep at room temperature.
• Prescription: Typically prescribed by oncologists.
• Counseling: Provide guidance on dosing and potential side effects.
• Pregnancy/Lactation: Caution advised; discuss risks with healthcare provider.
• Interactions: Check for potential interactions with other medications, particularly those metabolized by CYP3A4.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX

Strength	70 mg
Brand	DASATIB-70
Tablets per Pack	60 Tablets
Pack Size	1*60 Tablet
Pack Type	Box
Pack Type	Bottle
Form	Tablet
Brand Name	DASATIB
COMPOSITION	Dasatinib 70 Mg

Product Name: Dasatinib Tablets 70 MG
Brand Name: Dasatib 
Strength: 70 MG
Packing: 60 Tablets Per Box

• Name: Dasatinib Tablets
• Purpose: Treats certain types of leukemia and other cancers.
• Active Ingredient: Dasatinib.
• Dosage Form: Oral tablet.
• Dosage Strengths: Various strengths available.
• Indications: Used for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Mechanism of Action: Blocks proteins that promote cancer cell growth.
• Contraindications: Hypersensitivity.
• Adverse Reactions: Common side effects include nausea, diarrhea, headache; serious reactions may include fluid retention, bleeding.
• Storage: Store at room temperature.
• Manufacturer: Produced by pharmaceutical companies.
• Prescription: Typically prescribed by oncologists.
• Counseling: Instruct on proper dosing, potential side effects.
• Pregnancy/Lactation: Use with caution; potential risks.
• Interactions: Check for interactions with other medications, especially those metabolized by CYP3A4.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 60 TABLETS PER BOX

Strength	8mg
Brand	SAMROID-8
Form	Tablet
Packaging Size	100 tablets
Usage	Allergy
Packaging Type	Box
Also Gives	Third Party Manufacturing
Brand Name	Samroid-8

Product Name: Dexamethosone Tablets 
Brand Name: Samroid-8
Strength: 8 MG
Packing: 100 Tablets Per Box

• Name: Dexamethasone Tablets 8 mg
• Purpose: Used to treat various inflammatory conditions, autoimmune disorders, and certain cancers.
• Active Ingredient: Dexamethasone.
• Dosage Strength: Each tablet contains 8 mg of dexamethasone.
• Dosage Form: Oral tablet.
• Mechanism of Action: Suppresses inflammation and immune response by inhibiting multiple inflammatory pathways.
• Indications: Effective in conditions such as arthritis, asthma, allergic reactions, and certain cancers.
• Contraindications: Avoid in cases of hypersensitivity to dexamethasone or its components.
• Adverse Reactions: Common side effects include increased appetite, weight gain, insomnia, mood changes; long-term use may lead to serious complications like osteoporosis, diabetes, and immune suppression.
• Storage: Keep at room temperature away from moisture and heat.
• Prescription: Typically prescribed by healthcare providers based on patient's medical condition and history.
• Counseling: Educate patients on proper dosing, potential side effects, and importance of regular follow-up.
• Pregnancy/Lactation: Use with caution; risks and benefits should be evaluated, and usage should be under healthcare provider supervision.
• Interactions: Check for potential interactions with other medications, especially corticosteroids, immunosuppressants, and antibiotics.

Additional Information:

• Packaging Details: 100 TABLETS PER BOX

Strength	4 mg
Brand	SAMROID-4
Form	Tablet
Packaging Size	100 tablets
Usage	Allergy
Packaging Type	Box
Also Gives	Third Party Manufacturing
Brand Name	Samroid
Product Name	Dexamethosane Talets IP 4 MG

Product Name: Dexamethosane Talets IP 4 MG
Brand Nme: Samroid
Strength:4 mg
Packing: 100 Tablets Per Box

• Name: Dexamethasone Tablets IP 4 mg
• Purpose: Treats various inflammatory conditions, autoimmune disorders, and certain types of cancer.
• Active Ingredient: Dexamethasone.
• Dosage Strength: Each tablet contains 4 mg of dexamethasone.
• Dosage Form: Oral tablet.
• Mechanism of Action: Suppresses inflammation and immune response by inhibiting multiple inflammatory pathways.
• Indications: Used for conditions like arthritis, asthma, allergic reactions, and some cancers.
• Contraindications: Hypersensitivity to dexamethasone or components of the tablet.
• Adverse Reactions: Common side effects include increased appetite, weight gain, insomnia, and mood changes; long-term use may lead to more serious complications such as osteoporosis, diabetes, and immune suppression.
• Storage: Store at room temperature away from moisture and heat.
• Prescription: Typically prescribed by healthcare providers based on the patient's condition and medical history.
• Counseling: Instruct patients on proper dosing, potential side effects, and the importance of regular follow-up appointments.
• Pregnancy/Lactation: Use only if clearly needed and under the supervision of a healthcare provider; risks and benefits should be carefully weighed.
• Interactions: Check for potential interactions with other medications, especially other corticosteroids, immunosuppressants, and certain antibiotics.

Additional Information:

• Packaging Details: 100 TABLETS PER BOX

Strength	150 mg
Brand	ERLOSAM
Tablets per Pack	10 Tablets
Pack Size	1*10 Tablet
Pack Type	Strips
Usage	Lung Cancer
Form	Tablet
Pack Type	Strip
Prescription/Non prescription	Prescription
Brand Name	Erlosam
Manufacturer	Samarth Life Science Pvt. Ltd.
Country of Origin	Made in India

Product Name: Erolotinib Tablets IP 150 MG
Brand Name: Erlosam
Strength: 150 MG
Packing: 10 Tablets Per Box

Name: Erlotinib Tablets IP 150 mg
Purpose: Treats non-small cell lung cancer and pancreatic cancer.
Active Ingredient: Erlotinib.
Dosage Strength: Each tablet contains 150 mg of erlotinib.
Dosage Form: Oral tablet.
Mechanism of Action: Blocks signals in cancer cells that promote their growth.
Indications: Effective against specific types of lung and pancreatic cancers.
Contraindications: Hypersensitivity to erlotinib or its components.
Adverse Reactions: Common side effects include rash, diarrhea, nausea; serious reactions may include liver problems and lung issues.
Storage: Store at room temperature, protect from moisture.
Prescription: Typically prescribed by oncologists.
Counseling: Instruct on proper dosing, potential side effects, and the importance of regular follow-up.
Pregnancy/Lactation: Avoid during pregnancy or breastfeeding; discuss risks with healthcare provider.
Interactions: Check for potential interactions with other medications, especially those metabolized by CYP3A4.

Additional Information:

• Production Capacity: 10000
• Delivery Time: 3-4 weeks
• Packaging Details: 10 TABLETS PER BOX

Strength	20 mg
Dosage/Strength	20 mg
Brand	VALODEX-20
Tablets per Pack	100 Tablets
Usage	Breast Cancer
Pack Type	Strip
Form	Tablet
Brand Name	Valodex 20
Packing	100 Tablets Per Box
Product Name	Tamoxifen Citrate Tablets IP
Dosage Form	Oral tablet

Product Name: Tamoxifen Citrate Tablets IP
Brand Name: Valodex 20
Strength: 20 MG
Packing: 100 Tablets Per Box

• Name: Tamoxifen Citrate Tablets IP
• Purpose: Used in hormone therapy for breast cancer treatment and prevention.
• Active Ingredient: Tamoxifen Citrate.
• Dosage Form: Oral tablet.
• Mechanism of Action: Blocks estrogen receptors, inhibiting estrogen's effects on breast tissue.
• Indications: Treatment of hormone receptor-positive breast cancer, risk reduction in high-risk patients.
• Dosage Strengths: Available in various strengths, typically 10 mg or 20 mg per tablet.
• Contraindications: Hypersensitivity to tamoxifen or its components, history of blood clots or stroke.
• Adverse Reactions: Common side effects include hot flashes, vaginal dryness, and increased risk of uterine cancer; may also cause blood clots and cataracts.
• Storage: Store at room temperature, away from moisture and heat.
• Prescription: Typically prescribed by oncologists or breast cancer specialists.
• Counseling: Advise on proper dosing, potential side effects, and the importance of regular follow-up appointments.
• Pregnancy/Lactation: Not for use during pregnancy; discuss risks and benefits during lactation with healthcare provider.
• Interactions: Check for potential interactions with other medications, especially those affecting liver metabolism or blood clotting.

Additional Information:

• Packaging Details: 100 TABLETS PER BOX

Strength	1% w/v
Bottle Size	10 ml
Preservative	With Preservative
Use Case	Dry Eye
Dosage Form	Eye Drop
Patient Group	Adult & Paediatric
Manufactured By	Samarth Life Science Pvt. Ltd
Packaging Size	10 ml
Country of Origin	Made in India

Product Name: Carboxymethyl Cellulose Eye Drops
Brand Name: Lacrivisc DS
Strength: 10 ML
Packing: Single Bottle Per Box

^{Product Overview}

Lacrivisc DS (Carboxymethyl Cellulose Eye Drops 1%) by Genex Pharma is a sterile ophthalmic solution formulated to provide long-lasting relief from dry eye symptoms. Acting as a lubricant and artificial tear substitute, it helps restore natural moisture, alleviates irritation, and improves eye comfort in patients suffering from dryness, burning, or discomfort caused by environmental factors, prolonged screen use, or ocular conditions.

Advantages of Lacrivisc DS (Genex Pharma)

• Provides quick and long-lasting relief from dry eye symptoms.

• High-viscosity CMC 1% ensures effective lubrication.

• Safe and well-tolerated for regular use.

• Convenient 10 mL sterile bottle for patient compliance.

• Manufactured under strict quality standards by Genex Pharma.

 

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 Weeks
• Packaging Details: SINGLE BOTTLE PER BOX

Strength	2 mg
Storage Condition	Store below 25 DegreeC in the original packaging.
Country of Origin	Made in India
FORMS	Capsules

Product Name: Pomalidomide Capsules
Brand Name: Somalidomide
Strength: 2 MG
Packing: 21 Capsules Per Box

Composition
Active Ingredient: Pomalidomide – 2 mg
Excipients: Microcrystalline cellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, gelatin capsule shell (colorants and printing ink may vary by batch).

Indications
Pomalidomide is indicated for the treatment of:

Multiple Myeloma (MM):

In combination with dexamethasone for adult patients who have received at least two prior therapies (including lenalidomide and a proteasome inhibitor) and have demonstrated disease progression.
Kaposi’s Sarcoma (KS):
For adult patients with HIV-positive or HIV-negative KS who have failed prior systemic therapy (where approved by health authorities)

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 21 Capsules Per Box

Strength	4 mg
Storage Condition	Store below 25 DegreeC, in original packaging.
Country of Origin	Made in India

Product Name: Pomalidomide Capsules
Brand Name:Somalidomide
Strength: 4 MG
Packing:21 Capsules Per Box
Manufacturer: Samarth Life Science

Composition
Active Ingredient: Pomalidomide – 4 mg
Excipients: Microcrystalline cellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, gelatin capsule shell (colors and printing ink may vary).

Indications
Pomalidomide is used primarily in hematological cancers:

Multiple Myeloma (MM):

In combination with dexamethasone for patients who have received at least two prior therapies (including lenalidomide and a proteasome inhibitor) and have shown disease progression.

Kaposi’s Sarcoma (KS):

For patients with HIV-positive or HIV-negative KS after failure of other systemic therapy. (Where approved by regulatory authorities)

Storage
Store below 25°C, in original packaging.
Protect from light and moisture.
Keep away from children.



 

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 Weeks
• Packaging Details: 21 Capsules Per Box

Dose/Strength	200 mg
Injection Type	Lyophilized Powder
Strength	200 mg
Composition	Gemcitabine
Route	IV Infusion
Brand	LIFOGEM
Packaging Size	1 vial
Manufacturer	Samarth Life Sciences Pvt Ltd.
Packaging Type	Vial
Form	Injection
Packing	1 vial

Product Name: Gemcitabine Injection IP
Brand Name: Lifogem
Strength: 200 MG
Packing:Single Vial Per Box

1. Description:

   • Gemcitabine is a cytotoxic chemotherapy drug used to treat various cancers.
   • It is administered intravenously (IV) and comes in the form of a sterile, clear, colorless solution.

2. Mechanism of Action:

   • Gemcitabine interferes with the synthesis of DNA, inhibiting cell replication and causing cell death.

3. Indications:

   • Treatment of pancreatic cancer, non-small cell lung cancer, breast cancer, bladder cancer, and ovarian cancer.
   • Often used in combination with other chemotherapy agents or radiation therapy.

4. Administration:

   • Given as an intravenous infusion over a specified period, typically once a week or once every two weeks.
   • Dosage and schedule are determined by the patient's weight, health status, and type of cancer being treated.

5. Adverse Reactions:

   • Common side effects include nausea, vomiting, fatigue, fever, and flu-like symptoms.
   • Bone marrow suppression leading to decreased blood cell counts (anemia, neutropenia, thrombocytopenia) may occur.
   • Other potential adverse effects include liver toxicity, peripheral neuropathy, and skin rash.

6. Contraindications:

   • Hypersensitivity to gemcitabine or any of its components.
   • Severe renal impairment.
   • Pregnancy or breastfeeding due to potential harm to the fetus or infant.

7. Precautions:

   • Monitor blood cell counts regularly during treatment to detect and manage hematologic toxicity.
   • Assess renal function before initiating therapy and adjust dosage in patients with impaired renal function.
   • Use caution in patients with hepatic impairment or pre-existing peripheral neuropathy.

8. Drug Interactions:

   • Gemcitabine may interact with drugs that are metabolized by or affect renal function, potentially altering their efficacy or toxicity.
   • Inform healthcare providers about all medications, supplements, and herbal products being taken concurrently.

9. Storage:

   • Store gemcitabine vials at controlled room temperature (20-25°C).
   • Protect from light and moisture.
   • Follow specific storage instructions provided by the manufacturer.

10. Availability:

    • Gemcitabine is available in various strengths and packaging sizes for single or multiple doses.
    • Typically supplied as a sterile solution in single-dose vials or infusion bags.

11. Monitoring and Follow-Up:

    • Monitor for signs of treatment response, disease progression, and adverse reactions throughout the course of therapy.
    • Adjust dosage or treatment schedule as necessary based on patient response and tolerability.

12. Emergency Management:

    • Be prepared to manage potential infusion reactions, anaphylaxis, or severe adverse effects promptly and effectively.
    • Ensure healthcare providers administering gemcitabine are trained in chemotherapy administration and emergency response protocols.

Additional Information:

• Packaging Details: SINGLE VIAL PER BOX

Strength	160 mg
Brand	ENDACE-160
Pack Type	Strip
Pack Size	10*20 Tablet
Pack Type	Strips
Tablets per Pack	30 Tablets
Form	Tablet
Usage	Cancer Care
Brand Name	Endace-160
Manufacturer	samarth life science Pvt. Ltd
Country of Origin	Made in India

Product Name: Megestrol Acetate Tablets 160 MG
Brand Name: Endace-160
Strength: 160 MG
Packing: 30 Tablets Per Box

1. Description:

   • Megestrol acetate is a progestin medication used in hormone therapy and cancer treatment.
   • Available in tablet form for oral administration.

2. Mechanism of Action:

   • Exerts its effects by binding to progesterone receptors, leading to various hormonal and anti-cancer effects.

3. Indications:

   • Treatment of advanced breast cancer and endometrial cancer.
   • Management of anorexia, cachexia, or unintended weight loss in patients with AIDS or cancer.

4. Administration:

   • Administered orally, typically once daily.
   • Dosage and duration of treatment depend on the underlying condition and patient's response to therapy.

5. Adverse Reactions:

   • Common side effects include fluid retention, weight gain, increased appetite, and gastrointestinal disturbances.
   • Other potential adverse effects include thromboembolism, hyperglycemia, and mood changes.

6. Contraindications:

   • Hypersensitivity to megestrol acetate or any of its components.
   • History of thromboembolic disorders or breast cancer (in some cases).

7. Precautions:

   • Monitor for signs of thromboembolic events, hyperglycemia, or mood changes during treatment.
   • Use with caution in patients with a history of diabetes, cardiovascular disease, or depression.

8. Drug Interactions:

   • Megestrol acetate may interact with drugs that affect hormonal balance or metabolism, potentially altering their efficacy or toxicity.
   • Inform healthcare providers about all medications, supplements, and herbal products being taken concurrently.

9. Storage:

   • Store megestrol acetate tablets at room temperature (15-30°C) in a dry place away from direct sunlight.
   • Keep the tablets in their original packaging to protect them from moisture.

10. Availability:

    • Megestrol acetate tablets are available in 160 mg strength, typically supplied in blister packs or bottles.

11. Monitoring and Follow-Up:

    • Monitor for signs of treatment response, disease progression, and adverse reactions throughout the course of therapy.
    • Adjust dosage or treatment schedule as necessary based on patient response and tolerability.

12. Emergency Management:

    • Be prepared to manage potential adverse effects such as thromboembolism, hyperglycemia, or mood changes promptly and effectively.
    • Ensure healthcare providers prescribing and administering megestrol acetate are trained in oncology and hormone therapy management.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX

Strength	40 mg
Brand	ENDACE-40
Pack Size	10*20 Tablet
Tablets per Pack	40 Tablets
Form	Tablet
Usage	Cancer Care
Brand Name	ENDACE-40
Manufacturer	samarth life science Pvt. Ltd
Pack Type	Strip
Pack Type	Box

Product Name: Megestrol Acetate Tablets IP
Brand Name: Endace-40
Strength: 40 MG
Packing: 30 Tablets Per Box

1. Description:

   • Megestrol acetate is a synthetic progestin medication.
   • These tablets are formulated to contain 40 mg of megestrol acetate.
   • They are intended for oral administration.

2. Mechanism of Action:

   • Acts by binding to progesterone receptors, exerting hormonal and anti-cancer effects.

3. Indications:

   • Used in the treatment of advanced breast cancer and endometrial cancer.
   • Also prescribed to manage anorexia, cachexia, or unintended weight loss in patients with AIDS or cancer.

4. Administration:

   • Usually taken orally once daily.
   • Dosage and duration depend on the condition being treated and individual patient response.

5. Adverse Reactions:

   • Common side effects include fluid retention, weight gain, increased appetite, and gastrointestinal disturbances.
   • May also cause thromboembolism, hyperglycemia, or mood changes.

6. Contraindications:

   • Hypersensitivity to megestrol acetate or related components.
   • History of thromboembolic disorders or certain cancers.

7. Precautions:

   • Monitor for signs of adverse effects such as thromboembolism, hyperglycemia, or mood changes.
   • Use caution in patients with diabetes, cardiovascular disease, or depression.

8. Drug Interactions:

   • May interact with medications affecting hormonal balance or metabolism.
   • Inform healthcare providers about all concurrent medications.

9. Storage:

   • Store at room temperature (15-30°C) away from moisture and sunlight.

10. Availability:

    • Megestrol acetate tablets IP 40 mg are available in blister packs or bottles.

11. Monitoring and Follow-Up:

    • Regular monitoring for treatment response, disease progression, and adverse reactions is essential.
    • Dosage adjustments may be necessary based on patient's condition and tolerance.

12. Emergency Management:

    • Promptly manage potential adverse effects like thromboembolism or hyperglycemia.
    • Healthcare providers should be trained in managing complications associated with megestrol acetate therapy.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX

Strength	10 mg
Brand	BRAUNAMIDE
Capsules per Pack	30 Capsules
Packaging Size	30 Capsules
Usage	Cancer Care
Form	Capsule
Pack Type	Strip
Manfacturer	Samarth Life Science Pvt. Ltd
Country of Origin	Made in India

Product Name: Lenalidomide Capsules
Brand Name: Braunamide
Strength: 10 MG
Packing: 30 Capsules Per Box
Manufacturer:Genex Pharma

CompositionActive Ingredient: Lenalidomide – 10 mgExcipients: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, gelatin capsule shell (colors and printing ink may vary).IndicationsMultiple Myeloma (MM):In combination with dexamethasone for newly diagnosed or relapsed/refractory MM.As maintenance therapy post-autologous stem cell transplant.Myelodysplastic Syndromes (MDS):For transfusion-dependent anemia due to low or intermediate-1 risk MDS associated with a deletion 5q cytogenetic abnormality.Mantle Cell Lymphoma (MCL):For patients with relapsed or refractory disease.Follicular Lymphoma (FL):In combination with rituximab for previously treated Grade 1–3a FL.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: A 30 Capsules per Box

Molecule	Enzalutamide
Strength	40 mg
Form	Capsule
Packaging Type	Strip
Brand	Samluta
Dosage Form	Capsule
Usage	Hormone Refractory
Route of Administration	Oral
Packaging Size	56 Capsules Per Box
Used	For Oral used only

Product Name: Enzalutamide Capsules
Brand Name: Samluta
Strength: 40 MG
Packing: 56 Capsules Per Box

Key Features:
• Potent androgen receptor signaling inhibitor for advanced prostate cancer management
• Convenient oral capsule formulation, enhancing patient compliance
• Clinically proven to delay disease progression and improve survival outcomes
• Manufactured under strict GMP-certified facilities ensuring global quality and safety standards
• Supported by Genex Pharma’s commitment to delivering innovative oncology therapies worldwide.

Additional Information:

• Production Capacity: 10000
• Delivery Time: 4-5 Weeks
• Packaging Details: 56 Capsules Per Box

Composition	Palbociclib
Dose/Strength	100 mg
Brand	SAMITIB
Strength	100 mg
Packaging Size	120 CAPSULES PER BOX
Usage	CML
Tablets per Pack	120 Tablets
Manufacturer	Samarth Lifesciences
Form	Capsule
Packaging Type	Blister Pack
Country of Origin	Made in India
Brand Name	Samitib

Samitib Mesylate Cap 100Mg, Tab 400 Mg (Anti Cancer Capsules)

Samitib is used to treat certain types of cancer Samitib works by stopping or slowing the growth of cancer cells (tumors). It also works by causing cancer cells to die.

Indication:

Samitib is approved to treat:

• Acute lymphoblastic leukemia that is Philadelphia chromosome positive and has recurred(come back) or is refractory (does not respond to treatment).

• Chronic eosinophilic leukemia or hypereosinophilic syndrome.

• Chronic myelogenous leukemia that is Philadelphia chromosome positive.

• Dermato fibrosarcoma protuberans.

• Gastrointestinal stromal tumor (GIST).

• Myelodysplastic/myeloproliferative disorders.

• Systemic mastocytosis.

 

Packages:

Samitib Supplied as

• Samitib 100 Mg 120 capsules Per Boxes

• Samitib 400 Mg 30 Tablets Per Boxes.

Additional Information:

• Item Code: SAMITIB
• Production Capacity: 1000
• Delivery Time: 5-6 Weeks
• Packaging Details: 120 CAPSULES PER BOX

Strength	400 mg
Dose/Strength	400 mg
Brand	SAMITIB
Composition	Imatinib Base
Packaging Size	30 Tablets
Manufacturer	Samarth Life Science Pvt Ltd
Usage	Other Leukemia
Tablets per Pack	30 Tablets
Packaging Type	Box
Brand Name	Samitib
Manufactured By	Samarth

Imatinib Tablets (SAMITIB 400 mg)

1. Brand Name: SAMITIB 
2. Composition: Imatinib 400 mg per tablet
3. Form: Oral tablets
4. Therapeutic Use: Tyrosine kinase inhibitor used for the treatment of certain cancers
5. Mechanism of Action: Imatinib selectively inhibits the activity of BCR-ABL, a fusion protein that drives the growth of certain leukemia cells, and other tyrosine kinases involved in cancer cell proliferation.
6. Indications:
   • Chronic Myeloid Leukemia (CML)
   • Gastrointestinal Stromal Tumors (GISTs)
   • Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
   • Other malignancies like hypereosinophilic syndrome and chronic eosinophilic leukemia
7. Dosage: Taken orally, typically once or twice daily with food, as prescribed by the oncologist.
8. Packaging: 30 tablets of 400 mg each per box
9. Shelf Life: 24 months from manufacturing date
10. Storage Conditions: Store below 25°C, in a cool, dry place.
11. Key Features:

• Effective for chronic leukemia and GISTs
• Well-tolerated with manageable side effects
• Targeted therapy with minimal impact on normal cells

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 Tablets Per Box

Strength	150 mg
Dose/Strength	150 mg
Brand	Bracaloc
Tablets per Pack	30 Tablets
Usage/Application	Hospital
Usage	Breast Cancer
Form	Tablet
Pack Type	Strip
Packaging Size	150 mg
Country of Origin	Made in India

Product Name: Olaparib Tablets
Strength: 150 MG
Brand Name: Bracaloc
Packing: 30 Tablets

Mechanism of Action

• Inhibits the PARP enzyme, preventing DNA repair in cancer cells
• Especially effective in cells with BRCA1 or BRCA2 mutations
• Causes accumulation of genetic errors, leading to cancer cell death

Indications

1. Ovarian Cancer:
   • Maintenance treatment for BRCA-mutated advanced ovarian cancer
   • Used post first-line platinum-based chemotherapy
2. Breast Cancer:
   • Treatment for HER2-negative metastatic breast cancer with germline BRCA mutations
3. Prostate Cancer:
   • Treatment for metastatic castration-resistant prostate cancer (mCRPC) with HRR gene mutations
4. Pancreatic Cancer:
   • Maintenance treatment for germline BRCA-mutated metastatic pancreatic adenocarcinoma
   • Used post first-line platinum-based chemotherapy

Dosage and Administration

• Typical Dosage: 300 mg daily (two 150 mg tablets taken twice daily)
• Can be taken with or without food
• Adhere strictly to the prescribed regimen; consult healthcare provider before making any adjustments

Additional Information:

• Delivery Time: 4-5 weeks
• Packaging Details: 30 Tablets Per Box

Strength	100 mg
Dose/Strength	100 mg
Brand	Bracaloc
Tablets per Pack	30 Tablets
Usage/Application	Hospital
Usage	Breast Cancer
Form	Tablet
Pack Type	Strip
Country of Origin	Made in India

Product Name: Olaparib Tablets
Strength: 100 MG
Brand Name: Bracaloc
Packing: 30 Tablets Per Box

Indications

1. Ovarian Cancer:
   • Maintenance treatment for BRCA-mutated advanced ovarian cancer
   • Used after first-line platinum-based chemotherapy
2. Breast Cancer:
   • Treatment for HER2-negative metastatic breast cancer with germline BRCA mutations
3. Prostate Cancer:
   • Treatment for metastatic castration-resistant prostate cancer (mCRPC) with HRR gene mutations
4. Pancreatic Cancer:
   • Maintenance treatment for germline BRCA-mutated metastatic pancreatic adenocarcinoma
   • Used after first-line platinum-based chemotherapy

Dosage and Administration

• Typical Dosage: 300 mg taken orally twice daily
• Can be taken with or without food
• Follow prescribed regimen; do not adjust dose without consulting a healthcare provider

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 Tablets Per Box

Strength	200 mg
Packaging Size	30 Tablets
Brand	SORATIB-200
Manufacturer	Samarth Life Science Pvt Ltd
Composition	Sorafenib
Form	Tablet
Country of Origin	Made in India
Brand Name	Soratib-200
Manufactured By	Samarth
Packing	30 Tablets Per Box

Product Name:Sorafenib Tablets 200 MG
Brand Name: Soratib-200
Strength: 200 MG
Packing: 30 Tablets Per Box

1. Description:

   • Sorafenib is a targeted therapy medication.
   • These tablets contain 200 mg of sorafenib.
   • They are intended for oral administration.

2. Mechanism of Action:

   • Inhibits multiple tyrosine kinases, including those involved in tumor angiogenesis and cell proliferation.

3. Indications:

   • Used to treat advanced renal cell carcinoma (kidney cancer).
   • Also prescribed for unresectable hepatocellular carcinoma (liver cancer).

4. Administration:

   • Taken orally twice daily on an empty stomach, at least one hour before or two hours after meals.
   • Dosage and duration depend on the type and stage of cancer, as well as patient response.

5. Adverse Reactions:

   • Common side effects include diarrhea, hand-foot skin reaction, hypertension, and fatigue.
   • May also cause liver toxicity, thrombocytopenia, and gastrointestinal bleeding.

6. Contraindications:

   • Hypersensitivity to sorafenib or related components.
   • Pregnancy or breastfeeding due to potential harm to the fetus or infant.

7. Precautions:

   • Monitor blood pressure, liver function, and electrolytes regularly during treatment.
   • Use caution in patients with pre-existing cardiovascular disease, bleeding disorders, or renal impairment.

8. Drug Interactions:

   • May interact with medications affecting liver metabolism or prolonging the QT interval.
   • Inform healthcare providers about all concurrent medications.

9. Storage:

   • Store at room temperature (15-30°C) away from moisture and sunlight.

10. Availability:

    • Sorafenib tablets 200 mg are available in blister packs or bottles.

11. Monitoring and Follow-Up:

    • Regular monitoring for treatment response, disease progression, and adverse reactions is essential.
    • Adjust dosage or treatment schedule as needed based on patient's condition and tolerance.

12. Emergency Management:

    • Promptly manage potential adverse effects like hypertension or liver toxicity.
    • Healthcare providers should be trained in managing complications associated with sorafenib therapy.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX / 120 TABLETS PER BOX

Strength	100 mg
Packaging Size	30 Capsules
Pack Size	30 capsules
Brand	CAPBRUSAM
Usage/Application	Hospital
Composition	Acalabrutinib 100 mg
Indication	MCL
Prescription Type	Rx Only
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Product Name: Acalabrutinib Capsules
 
Brand Name: Capbrusam 

Strength: 100 MG

Packing: 30 Capsules Per Box

Mechanism of Action Inhibits BTK, an enzyme crucial for the survival and proliferation of B-cellsBlocks B-cell receptor signaling pathways, leading to reduced cancer cell growth and surviva
l
Indications

Chronic Lymphocytic Leukemia (CLL): Treatment of adults with CLLSmall Lymphocytic Lymphoma (SLL): Treatment of adults with SLLMantle Cell Lymphoma (MCL): Treatment of adults with MCL who have received at least one prior therapy

Dosage and Administration Typical Dosage: 100 mg taken orally twice dailyCan be taken with or without foodSwallow capsules whole; do not open, break, or chewFollow prescribed regimen and consult healthcare provider before any dose adjustments

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 Capsules Per Box

Strength	15 mg
Packaging Size	20 Tablets
Brand	Leucorin
Pack Size	10*10 Tablet
Composition	Leucovorin Calcium
Pack Type	Strips
Manufacturer	Samarth Life Science Pvt Ltd
Form	Tablet
Packaging Type	2 x 10 Tablets
Type Of Supplement	Calcium
Form Of Supplement	Tablets
Country of Origin	Made in India

Product Name: Calcium Folinate Tablets BP 15 MG
Brand Name: Leucorin 
Strength: 15 MG/ 2 ML
Packing: 20 Tablets Per Box

• Name: Calcium Folinate Tablet
• Purpose: Counters toxic effects of certain chemotherapy drugs.
• Active Ingredient: Calcium folinate (leucovorin calcium).
• Dosage Form: Oral tablet.
• Dosage Strengths: Available in various strengths.
• Indications: Adjunctive therapy for cancer treatment.
• Mechanism of Action: Provides folic acid to counter drug effects.
• Contraindications: Hypersensitivity, intrathecal administration.
• Adverse Reactions: Nausea, vomiting, diarrhea, rare bone marrow suppression.
• Storage: Room temperature, away from moisture.
• Manufacturer: Various companies.
• Prescription: Typically by oncologists.
• Counseling: Advise on dosing, side effects reporting.
• Pregnancy/Lactation: Use with caution.
• Interactions: Consider other medications affecting folate metabolism or renal function.

Additional Information:

• Delivery Time: 4-5 weeks
• Packaging Details: 20 TABLETS PER BOX

Strength	2.5mg
Brand	TREX
Tablets per Pack	100 Tablets
Pack Size	10*10 Tablets
Packaging Type	Strip
Usage	Cancer Care
Pack Type	Strip
Form	Tablet
Prescription/Non prescription	Prescription
Also Gives	PCD Pharma Franchise
Packaging Size	10 x 10 Tablets

Product Name: Methotrexate Tablets IP 
Brand Name: Trex
Strength: 2.5 MG
Packing: 100 Tablets Per Box

1. Description:

   • Methotrexate is a chemotherapy medication and immunosuppressant.
   • These tablets contain 2.5 mg of methotrexate.
   • They are intended for oral administration.

2. Mechanism of Action:

   • Works by inhibiting dihydrofolate reductase, interfering with DNA synthesis and cell proliferation.

3. Indications:

   • Used to treat various cancers, including leukemia, lymphoma, and breast cancer.
   • Also prescribed for autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

4. Administration:

   • Taken orally once a week or as directed by a healthcare provider.
   • Dosage and duration depend on the condition being treated and patient response.

5. Adverse Reactions:

   • Common side effects include nausea, vomiting, diarrhea, and mouth sores.
   • May also cause bone marrow suppression, liver toxicity, and lung problems.

6. Contraindications:

   • Hypersensitivity to methotrexate or related components.
   • Pregnancy or breastfeeding due to potential harm to the fetus or infant.

7. Precautions:

   • Monitor blood cell counts, liver function, and lung function regularly during treatment.
   • Use caution in patients with liver or kidney disease, alcoholism, or infections.

8. Drug Interactions:

   • May interact with medications affecting renal function, bone marrow, or liver metabolism.
   • Inform healthcare providers about all concurrent medications.

9. Storage:

   • Store at room temperature (15-30°C) away from moisture and sunlight.

10. Availability:

    • Methotrexate tablets 2.5 mg are available in blister packs or bottles.

11. Monitoring and Follow-Up:

    • Regular monitoring for treatment response, disease progression, and adverse reactions is essential.
    • Adjust dosage or treatment schedule as needed based on patient's condition and tolerance.

12. Emergency Management:

    • Promptly manage potential adverse effects like bone marrow suppression or liver toxicity.
    • Healthcare providers should be trained in managing complications associated with methotrexate therapy.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 100 TABLETS PER BOX

Strength	25 mg
Brand	Braunamide
Capsules per Pack	30 Capsules
Packaging Size	30 Capsules
Usage	Multiple Myeloma
Form	Capsule
Pack Type	Strip
Manfacturer	Samarath Life Science Pvt. Ltd
Country of Origin	Made in India

Product Name: Lenalidomide Capsules
Brand Nmae: Braunamide
Strength: 25 MG
Packing: 30 Capsules Per Box

Composition
Active Ingredient: Lenalidomide – 25 mg
Excipients: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, gelatin capsule shell (colors and printing ink may vary).

Indications

Lenalidomide is used in the treatment of several hematological malignancies:

Multiple Myeloma (MM):

In combination with dexamethasone for patients with newly diagnosed MM or relapsed/refractory MM.
As maintenance therapy following autologous stem cell transplantation.Myelodysplastic Syndromes (MDS):
For transfusion-dependent anemia due to low or intermediate-1 risk MDS associated with a deletion 5q cytogenetic abnormality.
Mantle Cell Lymphoma (MCL):
For patients with relapsed or refractory MCL.

Follicular Lymphoma (FL):

In combination with rituximab for previously treated Grade 1–3a FL.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 Capsules Per Box

Strength	5 mg
Brand	Braunamide
Capsules per Pack	30 Capsules
Packaging Size	30 Capsules
Usage	Multiple Myeloma
Form	Capsule
Pack Type	Strip
Manfacturer	Samarth Life Science Pvt. Ltd
Country of Origin	Made in India

Product: Lenalidomide Capsules
Brand Name: Braunamids
Strength: 5 MG
Packing: 30 Capsules Per Box
Manufacture: Samarth Life Science

. Composition
Active Ingredient: Lenalidomide – 5 mg
Excipients: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, gelatin capsule shell (colors and printing ink may vary depending on batch).
Indications
Lenalidomide is indicated for the treatment of various hematologic malignancies, including:

Multiple Myeloma (MM)

In combination with dexamethasone for newly diagnosed or relapsed/refractory MM.
As maintenance therapy after autologous stem cell transplantation.
Myelodysplastic Syndromes (MDS)
For transfusion-dependent anemia due to low or intermediate-1 risk MDS associated with a deletion 5q cytogenetic abnormality.
Mantle Cell Lymphoma (MCL)
For adult patients with relapsed or refractory MCL.

Follicular Lymphoma (FL)

In combination with rituximab for previously treated Grade 1–3a FL.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 Capsules Per Box

Brand	ANOSAM
Tablets per Pack	10 Tablets
Packaging Type	Stripe
Usage/Application	Hospital
Usage	Cancer Care
Pack Type	Strip
Form	Tablet
Manufacturer	Samarth Life Sciences Pvt Ltd.
Prescription/Non prescription	Prescription
Storage Instruction	Samarth Life Science Pvt. Ltd
Packaging Size	1 x 10 Tablets
Country of Origin	Made in India
Strength	0.5 mg

Product Name:Anastrazole Tablets
Brand Name: Anosam
Strength: 1 MG
Packing: 10 Tablets Per Box
Manufacturer: Genex Pharma

Description

Anosam contains Anastrozole, a potent and highly selective non-steroidal aromatase inhibitor. It works by reducing estrogen levels in the body, which helps slow or stop the growth of certain types of breast tumors that require estrogen to grow.

Mechanism of Action

Anastrozole selectively inhibits the aromatase enzyme, responsible for the conversion of androgens (produced in the adrenal glands) to estrogens in peripheral tissues. In postmenopausal women, this is the primary source of circulating estrogen. Lower estrogen levels help reduce tumor growth in estrogen receptor-positive (ER+) breast cancer.

Strength	40 mg
Brand	Samenza
Composition	Enzalutamide
Usage/Application	Hospital
Dosage Form	Capsule
Usage	Prostate Cancer
Form	Tablet
Units per Pack	28 Units
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Product Name: Enzalutamide Capsules 40 MG
Brand Name: Samenza 
Strength: 40 MG
Packing: 28 Capsules Per Box
 

Enzalutamide capsules 40 mg is a medication primarily used to treat prostate cancer that has spread to other parts of the body. Here's a concise description with pointers:

1. Purpose: Enzalutamide is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC), a form of prostate cancer that continues to grow despite hormonal therapy.

2. Administration: Administered orally as capsules, typically taken once daily with or without food.

3. Mechanism of Action: Enzalutamide inhibits androgen receptor signaling, blocking the effects of androgens (male hormones) on prostate cancer cells, thereby slowing cancer growth.

4. Indications: Used in the treatment of metastatic castration-resistant prostate cancer in patients who have previously received chemotherapy or as first-line therapy in patients who have not received chemotherapy.

5. Dosage: The recommended dosage is one 40 mg capsule taken orally once daily.

6. Side Effects: Common side effects may include fatigue, hot flashes, hypertension, diarrhea, and headache. Risk of seizures and falls may also occur.

7. Contraindications: Avoid use in patients with a known hypersensitivity to enzalutamide or any component of the formulation.

8. Precautions: Enzalutamide should be used cautiously in patients with a history of seizures, falls, or hypertension, as well as those with cardiovascular or cerebrovascular disease.

9. Storage: Store enzalutamide capsules according to manufacturer instructions, typically at controlled room temperature and protected from light.

10. Patient Monitoring: Regular monitoring of blood pressure, electrolytes, and liver function tests is recommended during treatment to assess for potential adverse effects and treatment response.

11. Education: Patients should be educated on the purpose of the medication, potential side effects, and the importance of adherence to the prescribed dosage regimen.

12. Follow-Up: Close follow-up with healthcare providers is necessary to monitor treatment response, manage side effects, and adjust the treatment plan as needed.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 WEEKS
• Packaging Details: 28 CAPSULES PER BOX / 56 CAPSULES PER BOX

Strength	250 mg
Brand	Flutide
Packaging Size	30 Tablets
Form	Tablet
Dose Type	Oral
Indication	Prostate Cancer
Manufacturer	Samarth Life Science Pvt Ltd
Packing	30 Tablets Per Box
Product Name	Flutamide Tablets IP

Product Name: Flutamide Tablets IP
Brand Name: Flutide
Strength:250 MG
Packing: 30 Tablets Per Box

Flutamide tablets IP are a medication primarily used to treat prostate cancer by blocking the effects of male hormones. Here's a concise description with pointers:

1. Purpose: Flutamide is indicated for the treatment of prostate cancer by blocking the action of androgens (male hormones) on cancer cells.

2. Administration: Administered orally as tablets, typically taken multiple times a day with or without food.

3. Mechanism of Action: Flutamide competitively inhibits androgen receptors, preventing the binding of testosterone and dihydrotestosterone to cancer cells, thereby slowing cancer growth.

4. Indications: Used in the treatment of metastatic prostate cancer, often in combination with other medications or treatments such as surgery or radiation therapy.

5. Dosage: Dosage varies based on the severity of the cancer and the patient's response to treatment, typically taken in divided doses.

6. Side Effects: Common side effects may include hot flashes, breast tenderness or enlargement, gastrointestinal disturbances, and liver toxicity. Rarely, lung toxicity or allergic reactions may occur.

7. Contraindications: Avoid use in patients with known hypersensitivity to flutamide or any components of the formulation, as well as those with severe hepatic impairment.

8. Precautions: Flutamide should be used cautiously in patients with liver disease, as it may cause liver toxicity. Regular liver function tests are recommended during treatment.

9. Storage: Store flutamide tablets according to manufacturer instructions, typically at controlled room temperature and protected from light and moisture.

10. Patient Monitoring: Regular monitoring of liver function, blood counts, and electrolytes is necessary during treatment to assess for potential adverse effects and treatment response.

11. Education: Patients should be educated on the purpose of the medication, potential side effects, and the importance of adherence to the prescribed dosage regimen.

12. Follow-Up: Close follow-up with healthcare providers is essential to monitor treatment response, manage side effects, and adjust the treatment plan as needed.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX

Strength	250 mg
Dose/Strength	250 mg
Brand	Geftib
Packaging Size	1*10 Tablets
Composition	Gefitinib
Dosage Form	Tablet
Prescription	Prescription
Usage/Application	Commercial
Manufacturer	SAMARTH LIFE SCIENCE PVT. LTD
Packaging Type	Box

Product Name: Gefitinib Tablets IP 
Brand Name: Unigef
Strength: 250 MG
Packing: 30 Tablets Per Box

Gefitinib tablets IP 250 mg is a medication primarily used to treat non-small cell lung cancer (NSCLC) that has specific genetic mutations. Here's a concise description with pointers:

1. Purpose: Gefitinib is indicated for the treatment of non-small cell lung cancer (NSCLC) that has specific epidermal growth factor receptor (EGFR) mutations.

2. Administration: Administered orally as tablets, usually taken once daily with or without food.

3. Mechanism of Action: Gefitinib inhibits the activity of EGFR tyrosine kinase, blocking the signals that promote cancer cell growth and proliferation.

4. Indications: Used for the first-line treatment of metastatic NSCLC with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations.

5. Dosage: The standard dosage is 250 mg taken orally once daily until disease progression or unacceptable toxicity occurs.

6. Side Effects: Common side effects may include diarrhea, rash, acne, nausea, and fatigue. Serious adverse reactions such as interstitial lung disease or liver toxicity may occur.

7. Contraindications: Avoid use in patients with a known hypersensitivity to gefitinib or any components of the formulation.

8. Precautions: Gefitinib should be used cautiously in patients with a history of liver or kidney disease, as well as those with a history of interstitial lung disease.

9. Storage: Store gefitinib tablets according to manufacturer instructions, typically at controlled room temperature and protected from light and moisture.

10. Patient Monitoring: Regular monitoring of liver function tests, renal function, and signs of interstitial lung disease is necessary during treatment.

11. Education: Patients should be educated on the purpose of the medication, potential side effects, and the importance of adherence to the prescribed dosage regimen.

12. Follow-Up: Close follow-up with healthcare providers is essential to monitor treatment response, manage side effects, and adjust the treatment plan as needed.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 weeks
• Packaging Details: 30 TABLETS PER BOX

Packaging Size	30 Tablets
Brand	SAMEXA
Composition	Exemestane
Dosage Form	Tablet
Prescription	Prescription
Strength	25 mg
Product Name	Exemestane Tablets IP
Brand Name	Samexa
Packing	30 Tablets Per Box

Product Name: Exemestane Tablets IP
Brand Name: Samexa
Strength: 25 MG
Packing: 30 Tablets Per Box

• Name: Exemestane Tablets 25 mg
• Purpose: Treats hormone receptor-positive breast cancer in postmenopausal women.
• Active Ingredient: Exemestane.
• Dosage Strength: Each tablet contains 25 mg of exemestane.
• Dosage Form: Oral tablet.
• Mechanism of Action: Reduces estrogen levels by inhibiting aromatase enzyme.
• Indications: Used as adjuvant therapy after tamoxifen treatment or for advanced breast cancer.
• Contraindications: Hypersensitivity to exemestane or its components.
• Adverse Reactions: Common side effects include hot flashes, fatigue, joint pain; may also cause osteoporosis and increased cholesterol levels.
• Storage: Store at room temperature, protect from moisture and heat.
• Prescription: Typically prescribed by oncologists or healthcare providers specializing in breast cancer treatment.
• Counseling: Educate on proper dosing, potential side effects, and the importance of bone health.
• Pregnancy/Lactation: Not for use in pregnant or breastfeeding women.
• Interactions: Check for potential interactions with other medications, especially those affecting liver enzymes or hormones.

Additional Information:

• Production Capacity: 1000
• Delivery Time: 4-5 WEEKS
• Packaging Details: 30 TABLETS PER BOX